1. Tianeptina: ¿por qué en España no ha sido catalogada como estupefaciente?;Calabozo;Rev Psiquiatr Salud Ment (Barc.),2016
2. Haute Autorité de Santé (HAS). Comission de la transparence. Avis, 5 decembre 2012. [Fecha de consulta 4 de Julio de 2016]. Disponible en: http://www.has-sante.fr/portail/upload/docs/evamed/CT2029_STABLON_ReevalSMR_avis2_CT10411_CT12029.pdf
3. Comité technique des Centres d’Evaluation et d’Information sur la Pharmacodépendance-CT022013043 Zolad,2014
4. The neurobiological properties of tianeptine (Stablon): From monoamine hypothesis to glutamatergic modulation;McEwen;Mol Psychiatry,2010
5. Influence of anxiety symptoms on improvement of neurocognitive functions in patients with major depressive disorder: A 12-week, multicenter, randomized trial of tianeptine versus escitalopram, the CAMPION study;Yoo;J Affect Disord,2015